⌘K

Aprea Therapeutics, Inc. (APRE)

$3.43 -2.56% $-0.09 Healthcare

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.

Market cap

$18.64M

CEO

Dr. Oren Gilad Ph.D.

Full time employees

16.00

Headquarters

Boston, MA

IPO Date

Oct 03, 2019

Price-to-earnings (PE) Ratio

-1.14

Earnings-per-share (EPS)

$-3.01

Cash ratio (TTM)

7.22

Current ratio (TTM)

7.28

Net profit margin (TTM)

-1,412.56%

PE ratio (TTM)

-1.55

PEG ratio (TTM)

-0.02

Price-to-book ratio (TTM)

0.95

Price-to-sales ratio (TTM)

20.01

Quick ratio (TTM)

7.28

Return on assets (TTM)

-50.22%

Return on equity (TTM)

-55.52%

Similar stocks (10)

AnaptysBio, Inc.

ANAB

$21.50 -4.02% $-0.90

Downtrend

Rezolute, Inc.

RZLT

$5.74 -3.69% $-0.22

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$8.39 1.94% $0.16

Uptrend

Generation Bio Co.

GBIO

$2.05 -5.96% $-0.13

Downtrend

Armata Pharmaceuticals, Inc.

ARMP

$2.75 22.22% $0.50

Downtrend

Ikena Oncology, Inc.

IKNA

$1.76 0.57% $0.01

Uptrend

Anebulo Pharmaceuticals, Inc.

ANEB

$1.65 -2.37% $-0.04

Downtrend

Lumos Pharma, Inc.

LUMO

$4.36 -0.23% $-0.00

Uptrend

RenovoRx, Inc.

RNXT

$1.08 -6.87% $-0.08

Downtrend

Forte Biosciences, Inc.

FBRX

$5.68 8.75% $0.46

Downtrend

ETF Exposure (2)

Dimensional U.S. Targeted Value ETF

DFAT

1.5558e-4%

$59.32 -1.23% $-0.74

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

4.33e-6%

$35.93 -0.53% $-0.19

Uptrend

Downtrend

Similar stocks (10)

AnaptysBio, Inc.

ANAB

$21.50 -4.02% $-0.90

Downtrend

Rezolute, Inc.

RZLT

$5.74 -3.69% $-0.22

Uptrend

Acrivon Therapeutics, Inc. Common Stock

ACRV

$8.39 1.94% $0.16

Uptrend

Generation Bio Co.

GBIO

$2.05 -5.96% $-0.13

Downtrend

Armata Pharmaceuticals, Inc.

ARMP

$2.75 22.22% $0.50

Downtrend

Ikena Oncology, Inc.

IKNA

$1.76 0.57% $0.01

Uptrend

Anebulo Pharmaceuticals, Inc.

ANEB

$1.65 -2.37% $-0.04

Downtrend

Lumos Pharma, Inc.

LUMO

$4.36 -0.23% $-0.00

Uptrend

RenovoRx, Inc.

RNXT

$1.08 -6.87% $-0.08

Downtrend

Forte Biosciences, Inc.

FBRX

$5.68 8.75% $0.46

Downtrend

ETF Exposure (2)

Dimensional U.S. Targeted Value ETF

DFAT

1.5558e-4%

$59.32 -1.23% $-0.74

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

4.33e-6%

$35.93 -0.53% $-0.19

Uptrend